Literature DB >> 28434038

Emerging potential of gene silencing approaches targeting anti-chondrogenic factors for cell-based cartilage repair.

Andrea Lolli1, Letizia Penolazzi2, Roberto Narcisi3, Gerjo J V M van Osch3,4, Roberta Piva5.   

Abstract

The field of cartilage repair has exponentially been growing over the past decade. Here, we discuss the possibility to achieve satisfactory regeneration of articular cartilage by means of human mesenchymal stem cells (hMSCs) depleted of anti-chondrogenic factors and implanted in the site of injury. Different types of molecules including transcription factors, transcriptional co-regulators, secreted proteins, and microRNAs have recently been identified as negative modulators of chondroprogenitor differentiation and chondrocyte function. We review the current knowledge about these molecules as potential targets for gene knockdown strategies using RNA interference (RNAi) tools that allow the specific suppression of gene function. The critical issues regarding the optimization of the gene silencing approach as well as the delivery strategies are discussed. We anticipate that further development of these techniques will lead to the generation of implantable hMSCs with enhanced potential to regenerate articular cartilage damaged by injury, disease, or aging.

Entities:  

Keywords:  Anti-chondrogenic regulators; Cartilage repair; Chondrogenesis; Gene silencing; Mesenchymal stem cells; MicroRNA; RNA interference

Mesh:

Substances:

Year:  2017        PMID: 28434038     DOI: 10.1007/s00018-017-2531-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  123 in total

Review 1.  Biocompatible quantum dots for biological applications.

Authors:  Sandra J Rosenthal; Jerry C Chang; Oleg Kovtun; James R McBride; Ian D Tomlinson
Journal:  Chem Biol       Date:  2011-01-28

2.  Differential Regulation of SOX9 Protein During Chondrogenesis of Induced Pluripotent Stem Cells Versus Mesenchymal Stromal Cells: A Shortcoming for Cartilage Formation.

Authors:  Solvig Diederichs; Jessica Gabler; Jennifer Autenrieth; Katharina L Kynast; Christian Merle; Heike Walles; Jochen Utikal; Wiltrud Richter
Journal:  Stem Cells Dev       Date:  2016-03-23       Impact factor: 3.272

3.  Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145).

Authors:  Aida Martinez-Sanchez; Katarzyna A Dudek; Chris L Murphy
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

4.  The infrapatellar fat pad from diseased joints inhibits chondrogenesis of mesenchymal stem cells.

Authors:  W Wei; E Rudjito; N Fahy; J A Verhaar; S Clockaerts; Y M Bastiaansen-Jenniskens; G J van Osch
Journal:  Eur Cell Mater       Date:  2015-12-02       Impact factor: 3.942

5.  Characterization and comparison of two novel nanosystems associated with siRNA for cellular therapy.

Authors:  E M André; A Pensado; P Resnier; L Braz; A M Rosa da Costa; C Passirani; A Sanchez; C N Montero-Menei
Journal:  Int J Pharm       Date:  2015-11-23       Impact factor: 5.875

6.  Delivery of siRNA via cationic Sterosomes to enhance osteogenic differentiation of mesenchymal stem cells.

Authors:  Zhong-Kai Cui; Jiabing Fan; Soyon Kim; Olga Bezouglaia; Armita Fartash; Benjamin M Wu; Tara Aghaloo; Min Lee
Journal:  J Control Release       Date:  2015-08-21       Impact factor: 9.776

7.  MMP-2 functions as a negative regulator of chondrogenic cell condensation via down-regulation of the FAK-integrin beta1 interaction.

Authors:  Eun-Jung Jin; Young-Ae Choi; Eui Kyun Park; Ok-Sun Bang; Shin-Sung Kang
Journal:  Dev Biol       Date:  2007-06-12       Impact factor: 3.582

Review 8.  Osteoarthritis in the XXIst century: risk factors and behaviours that influence disease onset and progression.

Authors:  Giuseppe Musumeci; Flavia Concetta Aiello; Marta Anna Szychlinska; Michelino Di Rosa; Paola Castrogiovanni; Ali Mobasheri
Journal:  Int J Mol Sci       Date:  2015-03-16       Impact factor: 5.923

Review 9.  Adipose, Bone Marrow and Synovial Joint-Derived Mesenchymal Stem Cells for Cartilage Repair.

Authors:  Christopher R Fellows; Csaba Matta; Roza Zakany; Ilyas M Khan; Ali Mobasheri
Journal:  Front Genet       Date:  2016-12-20       Impact factor: 4.599

Review 10.  lncRNAs: novel players in intervertebral disc degeneration and osteoarthritis.

Authors:  Wen-Kang Chen; Xiao-Hua Yu; Wei Yang; Cheng Wang; Wen-Si He; Yi-Guo Yan; Jian Zhang; Wen-Jun Wang
Journal:  Cell Prolif       Date:  2016-11-09       Impact factor: 6.831

View more
  3 in total

Review 1.  Intra-articular drug delivery systems for joint diseases.

Authors:  Muhammad Farooq Rai; Christine Tn Pham
Journal:  Curr Opin Pharmacol       Date:  2018-04-03       Impact factor: 5.547

2.  Long noncoding RNA expression profiles in chondrogenic and hypertrophic differentiation of mouse mesenchymal stem cells.

Authors:  Zhen Cao; Song Huang; Jianmei Li; Yun Bai; Ce Dou; Chuan Liu; Fei Kang; Xiaoshan Gong; Haibin Ding; Tianyong Hou; Shiwu Dong
Journal:  Funct Integr Genomics       Date:  2017-07-22       Impact factor: 3.410

3.  MicroRNA-193b-3p regulates chondrogenesis and chondrocyte metabolism by targeting HDAC3.

Authors:  Fangang Meng; Zhiwen Li; Zhiqi Zhang; Zibo Yang; Yan Kang; Xiaoyi Zhao; Dianbo Long; Shu Hu; Minghui Gu; Suiwen He; Peihui Wu; Zongkun Chang; Aishan He; Weiming Liao
Journal:  Theranostics       Date:  2018-04-15       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.